arrow
R

Raul C. Ribeiro

st jude childrens research hospital
H指数:98
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-Dose Cytarabine Plus G-CSF Induction in Pediatric M2 Acute Myeloid Leukemia: A Multicenter Study

低剂量阿糖胞苷联合G-CSF诱导治疗儿童M2型急性髓系白血病:一项多中心研究

2026-10-010
OAAI
Traumatic lumbar puncture at diagnosis in children and adolescents with acute lymphoblastic leukemia

儿童和青少年急性淋巴细胞白血病患者诊断时的创伤性腰椎穿刺

Leukemia
IF13.4
2026-07-310
PRE
Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessment

使用整合全基因组与转录组测序作为儿科及青少年急性髓系白血病诊断和风险评估框架的临床经验

Leukemia
IF13.4
2025-10-070
OA
Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia

急性髓系白血病的表观基因组学诊断与预后

2025-07-290
OAAI
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies

ETV6::RUNX1或高超二倍体B-ALL患者在接受St. Jude Total Therapy XV/XVI研究治疗后结果

BLOOD
IF23.1
2025-01-093
PRE
Outcomes of Children and Adolescents with Acute Myeloid Leukemia and KIT Mutations Treated with Low- or Standard-Dose Chemotherapy Plus Dasatinib on the CALSIII-AML18 Trial

CALSIII-AML18试验中,携带KIT突变且接受低剂量或标准剂量化疗联合达沙替尼治疗的儿童和青少年急性髓系白血病患者的结局

BLOOD
IF23.1
2024-11-050
PRE
Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

快速长读长表观基因组学对急性髓系白血病的诊断与预后

BLOOD
IF23.1
2024-11-050
PRE
Outcomes of Children and Adolescents with Acute Myeloid Leukemia and FLT3-ITD Treated with Low- or Standard-Dose Chemotherapy Plus Sorafenib on the Cals III-AML18 Trial (ChiCTR1800015883)

急性髓系白血病伴FLT3-ITD的儿童和青少年接受低剂量或标准剂量化疗联合索拉非尼治疗在Cals III-AML18试验(ChiCTR1800015883)中的结局

BLOOD
IF23.1
2024-11-050
PRE
Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid

急性早幼粒细胞白血病的早期死亡和颅内出血预测: 在接受化疗加全反式维甲酸治疗的国际联盟队列中验证风险评分

2024-10-310
OAAI
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials
2024-08-010
OAAI
Impact of a Regional Pediatric Hematology/Oncology Fellowship Program in Guatemala
2024-08-012
OA
International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects
2024-03-292
PRE
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
2024-01-014
OAAI